aTyr Pharma, Inc. (ATYR) Insider Trading
- $187,369.48
- $14,430.92
- Feb. 4, 2026
- Nancy Denyes
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 4, 2026 | General Counsel | 1,118 | $0.98 | Sell | $1,095.64 | |
| Feb. 4, 2026 | CEO | 3,745 | $0.98 | Sell | $3,670.10 | |
| Feb. 4, 2026 | CFO | 1,558 | $0.98 | Sell | $1,526.84 | |
| March 17, 2025 | Director | 3,750 | $4.00 | Buy | $15,000.00 | |
| Feb. 4, 2025 | General Counsel | 899 | $3.78 | Sell | $3,398.22 | |
| Feb. 4, 2025 | CFO | 1,254 | $3.78 | Sell | $4,740.12 | |
| July 24, 2024 | Director | 52,300 | $1.93 | Buy | $100,939.00 | |
| July 22, 2024 | Director | 41,052 | $1.74 | Buy | $71,430.48 |
Insiders are both buying and selling aTyr Pharma, Inc. stock.
The insider traders at aTyr Pharma, Inc. are: Jill Marie Broadfoot, Nancy Denyes, Paul Schimmel, Jane A Gross, and Sanjay Shukla
The most active insider trader at aTyr Pharma, Inc. is Jill Marie Broadfoot with 2 trades.
Jill Marie Broadfoot has sold the most aTyr Pharma, Inc. stock with a total value of $7,793.80.
Paul Schimmel has bought the most aTyr Pharma, Inc. stock with a total value of $273,308.48.
The most recent insider trade for aTyr Pharma, Inc. was on Feb. 4, 2026.
The single biggest insider buy for aTyr Pharma, Inc. was from Paul Schimmel with a total value of $100,939.00 on July 24, 2024.
The single biggest insider sell for aTyr Pharma, Inc. was from Jill Marie Broadfoot with a total value of $4,740.12 on Feb. 4, 2025.
